相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Review
Immunology
Taif Shah et al.
Summary: This article examines the pathogenesis and impact of coinfection between COVID-19 and TB, highlighting the diagnostic challenges associated with this dual infection.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Gabriel Tassi Mousquer et al.
Summary: Tuberculosis and COVID-19 are the leading causes of death among infectious diseases, with co-infection potentially causing immune system imbalance and exacerbating disease progression. Understanding the interactions between Mycobacterium tuberculosis and SARS-CoV-2 is crucial for developing therapeutic strategies against co-infection.
Article
Immunology
Paul Stamm et al.
Summary: The study compared the incidences of respiratory viruses in emergency room patients before and during the SARS-CoV-2 pandemic, showing significant decreases in positivity rates for Influenza A, Influenza B, and RSV, while the positivity rate for SARS-CoV-2 peaked at 9.74% during the second wave in December 2020. The findings suggest that measures related to COVID-19 and changes in human behavior patterns may lead to a decline or even elimination of other respiratory viruses such as influenza and RSV.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
(2021)
Article
Infectious Diseases
Linda Petrone et al.
Summary: The study revealed that COVID-19 patients with TB or LTBI have a diminished immune response to SARS-CoV-2 but retain the ability to respond to Mtb-specific antigens.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Infectious Diseases
Francesco Di Gennaro et al.
Summary: The study found that the COVID-19 pandemic had a significant impact on the care of TB patients, resulting in increased diagnostic delays, reduced hospitalizations, and more severe clinical presentations.
Article
Public, Environmental & Occupational Health
Sachin Silva et al.
Summary: Failure to achieve the SDG tuberculosis mortality target by 2030 will lead to profound economic and health losses, with the continuing decline in tuberculosis mortality rates driving global economic losses, and COVID-19 disruptions further adding to this cost.
LANCET GLOBAL HEALTH
(2021)
Article
Infectious Diseases
Masoud Dara et al.
Review
Infectious Diseases
C. F. McQuaid et al.
Summary: The COVID-19 pandemic has led to disruptions in TB health services, increased vulnerability to TB, limited evidence on changes in Mycobacterium tuberculosis transmission, and uncertainty about changes in resources needed for the TB response.Improving the available TB data is crucial for advocating for additional funding and efficiently allocating resources for the TB response.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
(2021)
Article
Medicine, Research & Experimental
Catherine Riou et al.
Summary: This study found that the attributes of SARS-CoV-2-specific CD4(+) T cells were associated with the severity of COVID-19, with severe cases showing poor polyfunctional potential, reduced proliferation capacity, and enhanced HLA-DR expression. HIV-1 and TB coinfection can alter the SARS-CoV-2 T cell response, with HIV-1 causing CD4(+) T cell depletion and active TB leading to decreased polyfunctional capacity of SARS-CoV-2-specific CD4(+) T cells in COVID-19 patients. Moreover, COVID-19 patients displayed a reduced frequency of Mycobacterium tuberculosis-specific CD4(+) T cells, which may affect TB disease progression.
JOURNAL OF CLINICAL INVESTIGATION
(2021)
Article
Infectious Diseases
Srinath Satyanarayana et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE
(2020)
